TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Dihydroartemisinin, Sorafenib
Phytochemical Name Dihydroartemisinin (PubChem CID: 3000518 )
Anticancer drug Name Sorafenib (PubChem CID: 216239 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 165
Pair Name Dihydroartemisinin, Sorafenib
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Ferroptosis
Gene Regulation Down-regulation Expression GCLC hsa2729
Down-regulation Expression GPX4 hsa2879
Down-regulation Expression GSS hsa2937
Down-regulation Expression HMOX1 hsa3162
Up-regulation Expression ROS1 hsa6098
Down-regulation Expression SLC7A11 hsa23657
Up-regulation Expression SMG1 hsa23049
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
SW480 Colon adenocarcinoma Homo sapiens (Human) CVCL_0546
In Vivo Model 5×10⁶ of HepG2 cells were injected into the right flank of 6-week-old athymic female mice (Balb/c nude mice).
Result DHA and Sora had the same mechanism, and the combined application of them could have a synergistic anti-tumor effect by inducing ferroptosis and inhibiting energy metabolism in HepG2 cells.
03. Reference
No. Title Href
1 Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism. J Pharmacol Sci. 2022 Jan;148(1):73-85. doi: 10.1016/j.jphs.2021.09.008. Click
It has been 46479 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP